These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8295990)

  • 1. The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data.
    Roberts SA; Hendry JH
    Radiother Oncol; 1993 Oct; 29(1):69-74. PubMed ID: 8295990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours.
    Dubben HH
    Radiother Oncol; 1994 Sep; 32(3):197-200. PubMed ID: 7816938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture.
    Tarnawski R; Widel M; Skladowski K
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1074-81. PubMed ID: 12605987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hazard of accelerated tumor clonogen repopulation during radiotherapy.
    Withers HR; Taylor JM; Maciejewski B
    Acta Oncol; 1988; 27(2):131-46. PubMed ID: 3390344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity.
    Roberts SA; Hendry JH
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):689-99. PubMed ID: 9635721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of tumour hypoxic fraction from clinical data sets compatible with accelerated repopulation.
    Jones B; Dale RG
    Acta Oncol; 1998; 37(3):263-8. PubMed ID: 9677098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.
    Roberts SA; Hendry JH
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1247-57. PubMed ID: 10613320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor.
    Roberts SA; Hendry JH; Brewster AE; Slevin NJ
    Br J Radiol; 1994 Aug; 67(800):790-4. PubMed ID: 8087485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How fast is repopulation of tumor cells during the treatment gap?
    Tarnawski R; Fowler J; Skladowski K; Swierniak A; Suwiński R; Maciejewski B; Wygoda A
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):229-36. PubMed ID: 12182996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose dependence of accelerated repopulation in head and neck cancer: Supporting evidence and clinical implications.
    Shuryak I; Hall EJ; Brenner DJ
    Radiother Oncol; 2018 Apr; 127(1):20-26. PubMed ID: 29534828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int j radiat oncol biol phys 2007;68:1491-1495).
    Fowler JF
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):326-9. PubMed ID: 18474309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer.
    Maciejewski B; Majewski S
    Radiother Oncol; 1991 Jul; 21(3):163-70. PubMed ID: 1924851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
    Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues.
    Hendry JH
    Radiother Oncol; 1992 Dec; 25(4):308-12. PubMed ID: 1480778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
    Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
    Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets.
    Roberts SA; Hendry JH; Slevin NJ
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1173-82. PubMed ID: 9392560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of delays in radiotherapy treatment on tumour control.
    Wyatt RM; Beddoe AH; Dale RG
    Phys Med Biol; 2003 Jan; 48(2):139-55. PubMed ID: 12587901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography.
    Johnson CR; Thames HD; Huang DT; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):281-7. PubMed ID: 7673015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
    Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
    Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.